Actuate Therapeutics, Inc. (ACTU) stock
ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.25−0.02 (-6.12%)
Close on Nov 17, 2026Market cap $6.04MP/E –Yield –
Actuate Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
No profit margin figures for Actuate Therapeutics
Actuate Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?